SECreport

Form 4 NAVIDEA BIOPHARMACEUTICA For: Jun 18 Filed by: Scott John K Jr.

Navidea Biopharmaceuticals, Inc.  (NAVB) 
NASDAQ:AMEX Investor Relations: ir.navidea.com